These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry. Yuan K; Jin YT; Lin MT J Periodontol; 2000 May; 71(5):701-9. PubMed ID: 10872949 [TBL] [Abstract][Full Text] [Related]
8. [Opening to the age of regenerative medicine--the mechanism of angiogenesis]. Murota S Kokubyo Gakkai Zasshi; 2002 Jun; 69(2):81-8. PubMed ID: 12136664 [No Abstract] [Full Text] [Related]
9. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. Hajitou A; Grignet C; Devy L; Berndt S; Blacher S; Deroanne CF; Bajou K; Fong T; Chiang Y; Foidart JM; Noël A FASEB J; 2002 Nov; 16(13):1802-4. PubMed ID: 12354694 [TBL] [Abstract][Full Text] [Related]
10. Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment. Fidler IJ J Natl Cancer Inst; 2001 Jul; 93(14):1040-1. PubMed ID: 11459857 [No Abstract] [Full Text] [Related]
11. Cancer experts offer healthy dose of skepticism toward hype over antiangiogenesis agents. Phillips P JAMA; 1998 Jun; 279(24):1936-7. PubMed ID: 9643843 [No Abstract] [Full Text] [Related]
12. [Vascular growth and non-small cell lung cancer]. Fan X; Guo X; Han B Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):499-502. PubMed ID: 11718044 [No Abstract] [Full Text] [Related]
13. [Antiangiogenic therapy]. Toi M Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900 [TBL] [Abstract][Full Text] [Related]
15. Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment. Hayes AJ; Li LY; Lippman ME BMJ; 1999 Mar; 318(7187):853-6. PubMed ID: 10092266 [No Abstract] [Full Text] [Related]
16. The role of thrombin in the neo-vascularization of malignant gliomas: an intrinsic modulator for the up-regulation of vascular endothelial growth factor. Yamahata H; Takeshima H; Kuratsu J; Sarker KP; Tanioka K; Wakimaru N; Nakata M; Kitajima I; Maruyama I Int J Oncol; 2002 May; 20(5):921-8. PubMed ID: 11956584 [TBL] [Abstract][Full Text] [Related]
17. Advances in the use of angiogenesis inhibitors in cancer. Pinedo HM Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080 [No Abstract] [Full Text] [Related]
18. Prognostic relevance of angiogenic, proliferative, and apoptotic factors in lung carcinomas. A case review. Volm M; Koomägi R Methods Mol Med; 2003; 74():269-82. PubMed ID: 12415702 [No Abstract] [Full Text] [Related]